The above studies examined the role of chemerin in NSCLC; however, at present, no studies examine serum or tissue levels of chemerin in patients with small-cell lung cancer, and only a single study examines its role in other forms of lung cancer. Here, RARRES2 is linked to non-small cell lung carcinoma.